Skip to main content
Federal & State Lawfederalstatelaw.com
All CRS Reports
R42890Health Policy

The Role of Patents and Regulatory Exclusivities in Pharmaceutical Innovation

Federal & State Law Editorial TeamLast reviewed: January 2013
January 7, 2013
Read full report on EveryCRSReport.com

Note: CRS reports are prepared for Members of Congress and their staffs. This summary is provided for informational purposes and does not constitute legal advice.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.